Participating Companies

(Partial list as of April 20, 2018; subject to change)

ACADIA Pharmaceuticals Inc. (ACAD)
Acceleron Pharma Inc. (XLRN) *
Achillion Pharmaceuticals, Inc. (ACHN)
Aclaris Therapeutics, Inc. (ACRS)
Adamas Pharmaceuticals, Inc. (ADMS)
Aerie Pharmaceuticals, Inc. (AERI)
Aerpio Pharmaceuticals, Inc. (ARPO)
Aevi Genomic Medicine, Inc. (GNMX)
Aimmune Therapeutics, Inc. (AIMT)
Akebia Therapeutics, Inc. (AKBA)
Alnylam Pharmaceuticals, Inc. (ALNY)
Alzheon, Inc. (Private)
AnaptysBio, Inc. (ANAB)
Aquestive Therapeutics, Inc. (Private)
Arbutus Biopharma Corporation (ABUS)
Arcturus Therapeutics Ltd.  (ARCT)
Arena Pharmaceuticals, Inc. (ARNA)
argenx SE (ARGX)
ArQule, Inc. (ARQL)
Arrowhead Pharmaceuticals, Inc. (ARWR)
Atara Biotherapeutics, Inc. (ATRA)
Avadel Pharmaceuticals plc (AVDL)
Avelas Biosciences (Private)
AxoGen, Inc. (AXGN)
Axovant Sciences Ltd. (AXON)
Bellerophon Therapeutics, Inc. (BLPH)
BioCryst Pharmaceuticals, Inc. (BCRX)
BioLine Rx Ltd (BLRX)
Bovie Medical Corporation (BVX)
Caelum Biosciences, Inc. (Private)
Calithera Biosciences, Inc. (CALA)
Checkpoint Therapeutics, Inc. (CKPT)
ChemoCentryx, Inc. (CCXI)
Clearside Biomedical, Inc. (CLSD)
Compugen Ltd. (CGEN)
Concert Pharmaceuticals, Inc. (CNCE)
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
CymaBay Therapeutics, Inc. (CBAY)
Cytokinetics, Incorporated (CYTK)
DBV Technologies S.A. (DBVT)
Deciphera Pharmaceuticals Inc. (DCPH)
Dermavant Sciences, Inc. (Private)
Edge Therapeutics, Inc. (EDGE)
Editas Medicine, Inc. (EDIT)
Egalet Corporation (EGLT)
electroCore, LLC (Private)
Enanta Pharmaceuticals, Inc. (ENTA)
Epizyme, Inc. (EPZM)
Erytech Pharma S.A. (ERYP)
Esperion Therapeutics, Inc. (ESPR)
Evelo Biosciences (Private)
Evolus, Inc. (EOLS)
Fortress Biotech, Inc. (FBIO)
Gamida Cell (Private)
Globus Medical, Inc. (GMED)
H3 Biomedicine Inc. (Private)
Haemonetics Corporation (HAE)
Halozyme Therapeutics, Inc. (HALO)
Heron Therapeutics, Inc. (HRTX)
Idera Pharmaceuticals, Inc. (IDRA)
Infinity Pharmaceuticals, Inc. (INFI)
Insmed Incorporated (INSM)
Integra LifeSciences Holdings Corporation (IART)
Intellia Therapeutics, Inc. (NTLA)
Intrexon Corporation (XON)
K2M Group Holdings, Inc. (KTWO)
Kadmon Holdings, Inc. (KDMN)
Karyopharm Therapeutics Inc. (KPTI)
Keryx Biopharmaceuticals, Inc. (KERX)
Kiniksa Pharmaceuticals (Private)
Kura Oncology, Inc. (KURA)
Leap Therapeutics, Inc. (LPTX)
Loxo Oncology, Inc. (LOXO)
Madrigal Pharmaceuticals, Inc. (MDGL)
Marinus Pharmaceuticals, Inc. (MRNS)
Melinta Therapeutics, Inc. (MLNT)
Menlo Therapeutics (MNLO)
Minerva Neurosciences, Inc. (NERV)
MorphoSys AG (MOR)
Mustang Bio, Inc. (MBIO)
Myovant Sciences Ltd. (MYOV)
Neos Therapeutics, Inc. (NEOS)
NeuroRx, Inc. (Private)
Novan, Inc. (NOVN)
Nuvectra Corporation (NVTR)
Ocular Therapeutix, Inc. (OCUL)
Ovid Therapeutics Inc. (OVID)
Pfenex Inc. (PFNX)
Pieris Pharmaceuticals, Inc. (PIRS)
Poxel SA (POXEL )
Proclara Biosciences (Private)
ProQR Therapeutics N.V. (PRQR)
Protagonist Therapeutics, Inc. (PTGX)
Proteon Therapeutics, Inc. (PRTO)
Realm Therapeutics Plc (RLM)
Regulus Therapeutics Inc. (RGLS)
Retrophin, Inc. (RTRX)
Revance Therapeutics, Inc. (RVNC)
RTI Surgical, Inc. (RTIX)
Savara Inc. (SVRA)
Sienna Biopharmaceuticals Inc. (SNNA)
Sol-Gel Technologies Ltd (SLGL)
Sophiris Bio Inc. (SPHS)
Spring Bank Pharmaceuticals, Inc. (SBPH)
SteadyMed Ltd. (STDY)
Strongbridge Biopharma plc (SBBP)
Summit Therapeutics plc (SMMT)
Syndax Pharmaceuticals, Inc. (SNDX)
Syros Pharmaceuticals, Inc. (SYRS)
Teligent, Inc. (TLGT)
Trevena, Inc. (TRVN)
Ultragenyx Pharmaceutical Inc. (RARE)
Vanda Pharmaceuticals Inc. (VNDA)
Verastem, Inc. (VSTM)
Verona Pharma plc (VRNA)
Xencor, Inc. (XNCR)

* Available for 1x1 Meetings Only